Tags (3) : biotech
Nuvation Bio's Taletrectinib Clears Key UK Regulatory Milestone for ROS1+ Lung Cancer
06/29/2026 | Companies
AACR Annual Meeting,
advanced lung cancer,
biotech,
cancer drug development,
cancer therapy,
cancer treatment advancements,
DOVBLERON,
Eisai,
Eisai partnership,
EMA,
European Medicines Agency,
FDA approval,
global healthcare,
IBTROZI,
International Recognition Procedure,
Journal of Clinical Oncology,
lung cancer research,
MAA,
Marketing Authorisation Application,
metastatic cancer treatment,
MHRA,
non-small cell lung cancer,
NSCLC treatment,
Nuvation Bio,
Nuvation Bio stock,
NYSE NUVB,
oncology,
oncology innovation,
pharmaceutical industry,
Phase 2 clinical trials,
precision medicine,
rare cancer mutations,
respiratory oncology,
ROS1-positive NSCLC,
ROS1+ lung cancer,
taletrectinib,
targeted therapy,
TRUST-I,
TRUST-II,
UK regulatory approval
Antimicrobial resistance key to fighting decease
02/28/2023 | Companies
addressing disease,
AMR,
antibiotic stewardship,
Antibiotics,
antimicrobial resistance,
bacterial infections,
biotech,
COVID-19 pandemic,
critical medicines,
diagnostic,
equitable availability,
generic,
generics,
healthcare professionals,
Lancet,
market viability,
medical journal,
pharmaceutical industries,
resistance to antibiotics,
stakeholders,
supply disruption
Illumina’s virtual lab opens immense learning possibilities for students
11/11/2022 | Companies
BCI,
Biocom California Institute,
biotech,
capstone course,
DNA Library Preparation and Sequencing Simulation Lab,
DNA sequencing,
fish species,
genetic differences,
genetic diversity,
genome sequencing,
IGD,
Illumina Genomic Discoveries,
micro pipetting,
PCR,
research project,
saltwater pond,
student,
virtual environment
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com


Companies